Allogene Therapeutics, Inc. (ALLO)
2.31
-0.22
(-8.70%)
USD |
NASDAQ |
Mar 05, 16:00
2.31
0.00 (0.00%)
After-Hours: 16:42
Allogene Therapeutics Free Cash Flow : -158.99M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 150.90M |
| Agenus, Inc. | -89.31M |
| Curis, Inc. | -30.09M |
| LadRx Corp. | -- |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.69M |
| Cash from Investing (Quarterly) | 11.94M |
| Cash from Financing (Quarterly) | 3.236M |
| Free Cash Flow Per Share (Quarterly) | -0.1348 |
| Free Cash Flow to Equity (Quarterly) | -28.08M |
| Free Cash Flow to Firm (Quarterly) | -29.59M |
| Free Cash Flow Yield | -31.76% |